lung cancer | |||||
新闻 | |||||
Ideaya Biosciences to present IDE397 phase 1 expansion results in MTAP-deletion lung ... ... lung cancer (NSCLC) patients at the 36th edition of the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics taking place on ...
| |||||
BerGenBio Announces Safety Data from Dose Escalation Phase 1b in First Line NSCLC Patients ... Lung Cancer (NSCLC) patients. The Phase 1b part of the study evaluated three escalating doses of BerGenBio's selective AXL inhibitor bemcentinib ...
| |||||
| |||||
查看更多结果 | 修改此快讯 |
您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
发送反馈 |
No comments:
Post a Comment